nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—peripheral nervous system neoplasm—skin cancer	0.241	0.509	CtDrD
Vincristine—sarcoma—skin cancer	0.232	0.49	CtDrD
Vincristine—TUBB6—Docetaxel—skin cancer	0.0291	0.0691	CbGbCtD
Vincristine—TUBB8—Docetaxel—skin cancer	0.0291	0.0691	CbGbCtD
Vincristine—TUBB4A—Docetaxel—skin cancer	0.0291	0.0691	CbGbCtD
Vincristine—TUBB2A—Docetaxel—skin cancer	0.0291	0.0691	CbGbCtD
Vincristine—TUBB3—Docetaxel—skin cancer	0.0291	0.0691	CbGbCtD
Vincristine—TUBB2B—Docetaxel—skin cancer	0.0291	0.0691	CbGbCtD
Vincristine—TUBB—Docetaxel—skin cancer	0.0243	0.0578	CbGbCtD
Vincristine—TUBB1—Docetaxel—skin cancer	0.0243	0.0578	CbGbCtD
Vincristine—TUBB4B—Docetaxel—skin cancer	0.0243	0.0578	CbGbCtD
Vincristine—ABCC1—Vemurafenib—skin cancer	0.0209	0.0497	CbGbCtD
Vincristine—ABCC10—Docetaxel—skin cancer	0.0186	0.0442	CbGbCtD
Vincristine—ABCG2—Vismodegib—skin cancer	0.0177	0.0421	CbGbCtD
Vincristine—ABCC3—Fluorouracil—skin cancer	0.0153	0.0364	CbGbCtD
Vincristine—ABCG2—Vemurafenib—skin cancer	0.014	0.0332	CbGbCtD
Vincristine—ABCC1—Dactinomycin—skin cancer	0.0139	0.033	CbGbCtD
Vincristine—ABCG2—Dactinomycin—skin cancer	0.00931	0.0221	CbGbCtD
Vincristine—ABCC1—Docetaxel—skin cancer	0.00718	0.017	CbGbCtD
Vincristine—ABCB1—Vismodegib—skin cancer	0.00639	0.0152	CbGbCtD
Vincristine—ABCG2—Fluorouracil—skin cancer	0.00629	0.0149	CbGbCtD
Vincristine—CYP3A4—Imiquimod—skin cancer	0.00552	0.0131	CbGbCtD
Vincristine—CYP3A4—Temozolomide—skin cancer	0.00552	0.0131	CbGbCtD
Vincristine—ABCC2—Docetaxel—skin cancer	0.00532	0.0126	CbGbCtD
Vincristine—ABCG2—Docetaxel—skin cancer	0.00481	0.0114	CbGbCtD
Vincristine—CYP3A4—Vismodegib—skin cancer	0.00383	0.00909	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.00355	0.00843	CbGbCtD
Vincristine—CYP3A7—Docetaxel—skin cancer	0.00355	0.00843	CbGbCtD
Vincristine—ABCB1—Dactinomycin—skin cancer	0.00336	0.00797	CbGbCtD
Vincristine—CYP3A4—Vemurafenib—skin cancer	0.00303	0.00718	CbGbCtD
Vincristine—CYP3A5—Docetaxel—skin cancer	0.00266	0.00632	CbGbCtD
Vincristine—ABCB1—Docetaxel—skin cancer	0.00173	0.00411	CbGbCtD
Vincristine—RALBP1—RalA downstream regulated genes—EXOC2—skin cancer	0.0017	0.298	CbGpPWpGaD
Vincristine—TUBB4B—Sorafenib—Vismodegib—skin cancer	0.00114	0.667	CbGdCrCtD
Vincristine—CYP3A4—Docetaxel—skin cancer	0.00104	0.00246	CbGbCtD
Vincristine—RALBP1—hair follicle—skin cancer	0.00102	0.0343	CbGeAlD
Vincristine—TUBB4B—skin epidermis—skin cancer	0.000946	0.0319	CbGeAlD
Vincristine—TUBB—hair follicle—skin cancer	0.000792	0.0267	CbGeAlD
Vincristine—TUBA4A—nipple—skin cancer	0.000732	0.0247	CbGeAlD
Vincristine—RALBP1—nipple—skin cancer	0.00069	0.0233	CbGeAlD
Vincristine—TUBB3—connective tissue—skin cancer	0.000684	0.0231	CbGeAlD
Vincristine—TUBB4B—hair follicle—skin cancer	0.000675	0.0228	CbGeAlD
Vincristine—NR0B1—female reproductive system—skin cancer	0.000657	0.0222	CbGeAlD
Vincristine—TUBB8—head—skin cancer	0.000591	0.0199	CbGeAlD
Vincristine—TUBB2B—nipple—skin cancer	0.000567	0.0191	CbGeAlD
Vincristine—TUBB6—Sorafenib—Vismodegib—skin cancer	0.000567	0.333	CbGdCrCtD
Vincristine—TUBB—nipple—skin cancer	0.000537	0.0181	CbGeAlD
Vincristine—TUBB2A—nipple—skin cancer	0.000534	0.018	CbGeAlD
Vincristine—TUBB6—nipple—skin cancer	0.000527	0.0178	CbGeAlD
Vincristine—TUBA4A—connective tissue—skin cancer	0.000519	0.0175	CbGeAlD
Vincristine—TUBB3—lymphoid tissue—skin cancer	0.0005	0.0169	CbGeAlD
Vincristine—TUBA4A—epithelium—skin cancer	0.000493	0.0166	CbGeAlD
Vincristine—ABCC1—hair follicle—skin cancer	0.000481	0.0162	CbGeAlD
Vincristine—RALBP1—Rho GTPase cycle—RHOU—skin cancer	0.000474	0.0834	CbGpPWpGaD
Vincristine—TUBA4A—skin of body—skin cancer	0.000469	0.0158	CbGeAlD
Vincristine—ABCC10—nipple—skin cancer	0.000461	0.0155	CbGeAlD
Vincristine—TUBB4B—nipple—skin cancer	0.000458	0.0154	CbGeAlD
Vincristine—TUBA4A—mammalian vulva—skin cancer	0.000428	0.0144	CbGeAlD
Vincristine—TUBB4A—connective tissue—skin cancer	0.000416	0.014	CbGeAlD
Vincristine—RALBP1—mammalian vulva—skin cancer	0.000403	0.0136	CbGeAlD
Vincristine—TUBB3—head—skin cancer	0.000403	0.0136	CbGeAlD
Vincristine—TUBB2B—connective tissue—skin cancer	0.000402	0.0136	CbGeAlD
Vincristine—SLC22A3—nipple—skin cancer	0.000395	0.0133	CbGeAlD
Vincristine—TUBB1—head—skin cancer	0.000394	0.0133	CbGeAlD
Vincristine—TUBA4A—lymphoid tissue—skin cancer	0.00038	0.0128	CbGeAlD
Vincristine—TUBB2A—connective tissue—skin cancer	0.000379	0.0128	CbGeAlD
Vincristine—TUBB4A—skin of body—skin cancer	0.000376	0.0127	CbGeAlD
Vincristine—TUBA4A—female reproductive system—skin cancer	0.000366	0.0123	CbGeAlD
Vincristine—TUBB6—epithelium—skin cancer	0.000355	0.012	CbGeAlD
Vincristine—RALBP1—female reproductive system—skin cancer	0.000345	0.0116	CbGeAlD
Vincristine—TUBB2A—skin of body—skin cancer	0.000342	0.0115	CbGeAlD
Vincristine—TUBB6—skin of body—skin cancer	0.000337	0.0114	CbGeAlD
Vincristine—TUBB2B—mammalian vulva—skin cancer	0.000331	0.0112	CbGeAlD
Vincristine—ABCC1—nipple—skin cancer	0.000326	0.011	CbGeAlD
Vincristine—TUBB4B—connective tissue—skin cancer	0.000325	0.0109	CbGeAlD
Vincristine—TUBB—mammalian vulva—skin cancer	0.000314	0.0106	CbGeAlD
Vincristine—TUBB2A—mammalian vulva—skin cancer	0.000312	0.0105	CbGeAlD
Vincristine—TUBB6—mammalian vulva—skin cancer	0.000308	0.0104	CbGeAlD
Vincristine—TUBA4A—head—skin cancer	0.000306	0.0103	CbGeAlD
Vincristine—TUBB4A—lymphoid tissue—skin cancer	0.000304	0.0103	CbGeAlD
Vincristine—TUBB4A—female reproductive system—skin cancer	0.000294	0.0099	CbGeAlD
Vincristine—TUBB4B—skin of body—skin cancer	0.000293	0.00988	CbGeAlD
Vincristine—RALBP1—head—skin cancer	0.000288	0.00972	CbGeAlD
Vincristine—TUBB2B—female reproductive system—skin cancer	0.000284	0.00957	CbGeAlD
Vincristine—SLC22A3—connective tissue—skin cancer	0.00028	0.00943	CbGeAlD
Vincristine—TUBB6—lymphoid tissue—skin cancer	0.000273	0.00921	CbGeAlD
Vincristine—ABCC10—mammalian vulva—skin cancer	0.000269	0.00908	CbGeAlD
Vincristine—TUBB4B—mammalian vulva—skin cancer	0.000267	0.00901	CbGeAlD
Vincristine—TUBB2A—female reproductive system—skin cancer	0.000267	0.009	CbGeAlD
Vincristine—TUBB6—female reproductive system—skin cancer	0.000263	0.00888	CbGeAlD
Vincristine—TUBB4A—head—skin cancer	0.000245	0.00827	CbGeAlD
Vincristine—ABCC10—lymphoid tissue—skin cancer	0.000239	0.00806	CbGeAlD
Vincristine—TUBB4B—lymphoid tissue—skin cancer	0.000237	0.008	CbGeAlD
Vincristine—TUBB2B—head—skin cancer	0.000237	0.00799	CbGeAlD
Vincristine—SLC22A3—Synaptic Vesicle Pathway—SYP—skin cancer	0.000237	0.0417	CbGpPWpGaD
Vincristine—ABCC3—female reproductive system—skin cancer	0.000232	0.00781	CbGeAlD
Vincristine—ABCC10—female reproductive system—skin cancer	0.000231	0.00778	CbGeAlD
Vincristine—SLC22A3—mammalian vulva—skin cancer	0.00023	0.00777	CbGeAlD
Vincristine—TUBB4B—female reproductive system—skin cancer	0.000229	0.00772	CbGeAlD
Vincristine—TUBB2A—head—skin cancer	0.000223	0.00752	CbGeAlD
Vincristine—TUBB6—head—skin cancer	0.00022	0.00742	CbGeAlD
Vincristine—TUBA4A—lymph node—skin cancer	0.000214	0.00722	CbGeAlD
Vincristine—RALBP1—lymph node—skin cancer	0.000202	0.00681	CbGeAlD
Vincristine—RALBP1—RalA downstream regulated genes—NRAS—skin cancer	0.000201	0.0354	CbGpPWpGaD
Vincristine—ABCC3—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000199	0.0349	CbGpPWpGaD
Vincristine—SLC22A3—female reproductive system—skin cancer	0.000197	0.00665	CbGeAlD
Vincristine—ABCC3—head—skin cancer	0.000194	0.00653	CbGeAlD
Vincristine—TUBB4B—head—skin cancer	0.000191	0.00645	CbGeAlD
Vincristine—ABCC1—mammalian vulva—skin cancer	0.000191	0.00642	CbGeAlD
Vincristine—ABCC2—female reproductive system—skin cancer	0.000185	0.00624	CbGeAlD
Vincristine—ABCB1—blood vessel—skin cancer	0.000184	0.00621	CbGeAlD
Vincristine—Weight decreased—Bleomycin—skin cancer	0.000183	0.00266	CcSEcCtD
Vincristine—Nausea—Vismodegib—skin cancer	0.000183	0.00265	CcSEcCtD
Vincristine—Agitation—Imiquimod—skin cancer	0.000183	0.00265	CcSEcCtD
Vincristine—Pneumonia—Bleomycin—skin cancer	0.000182	0.00264	CcSEcCtD
Vincristine—Pancytopenia—Dactinomycin—skin cancer	0.000179	0.0026	CcSEcCtD
Vincristine—Acute coronary syndrome—Bleomycin—skin cancer	0.000178	0.00258	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.000178	0.00258	CcSEcCtD
Vincristine—Hypotension—Vemurafenib—skin cancer	0.000178	0.00258	CcSEcCtD
Vincristine—Myocardial infarction—Bleomycin—skin cancer	0.000177	0.00257	CcSEcCtD
Vincristine—Neutropenia—Dactinomycin—skin cancer	0.000177	0.00256	CcSEcCtD
Vincristine—Stomatitis—Bleomycin—skin cancer	0.000176	0.00255	CcSEcCtD
Vincristine—Muscular weakness—Temozolomide—skin cancer	0.000174	0.00253	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000173	0.00251	CcSEcCtD
Vincristine—Cardiac arrest—Fluorouracil—skin cancer	0.000173	0.00251	CcSEcCtD
Vincristine—RALBP1—RalA downstream regulated genes—KRAS—skin cancer	0.000173	0.0305	CbGpPWpGaD
Vincristine—Convulsion—Imiquimod—skin cancer	0.000172	0.0025	CcSEcCtD
Vincristine—TUBB4A—lymph node—skin cancer	0.000172	0.00579	CbGeAlD
Vincristine—Hypertension—Imiquimod—skin cancer	0.000172	0.00249	CcSEcCtD
Vincristine—Ataxia—Fluorouracil—skin cancer	0.000171	0.00249	CcSEcCtD
Vincristine—Neuropathy—Docetaxel—skin cancer	0.00017	0.00247	CcSEcCtD
Vincristine—Pneumonia—Dactinomycin—skin cancer	0.000169	0.00246	CcSEcCtD
Vincristine—Myalgia—Imiquimod—skin cancer	0.000169	0.00245	CcSEcCtD
Vincristine—TUBB2B—lymph node—skin cancer	0.000166	0.0056	CbGeAlD
Vincristine—Decreased appetite—Vemurafenib—skin cancer	0.000165	0.0024	CcSEcCtD
Vincristine—SLC22A3—head—skin cancer	0.000165	0.00556	CbGeAlD
Vincristine—Stomatitis—Dactinomycin—skin cancer	0.000164	0.00238	CcSEcCtD
Vincristine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000164	0.00238	CcSEcCtD
Vincristine—Fatigue—Vemurafenib—skin cancer	0.000164	0.00238	CcSEcCtD
Vincristine—Constipation—Vemurafenib—skin cancer	0.000163	0.00236	CcSEcCtD
Vincristine—Pancytopenia—Temozolomide—skin cancer	0.000162	0.00235	CcSEcCtD
Vincristine—Oedema—Imiquimod—skin cancer	0.000162	0.00235	CcSEcCtD
Vincristine—Hypoaesthesia—Bleomycin—skin cancer	0.000161	0.00234	CcSEcCtD
Vincristine—Infection—Imiquimod—skin cancer	0.000161	0.00234	CcSEcCtD
Vincristine—Muscular weakness—Fluorouracil—skin cancer	0.000161	0.00233	CcSEcCtD
Vincristine—Dysuria—Temozolomide—skin cancer	0.00016	0.00232	CcSEcCtD
Vincristine—Neutropenia—Temozolomide—skin cancer	0.00016	0.00232	CcSEcCtD
Vincristine—Nervous system disorder—Imiquimod—skin cancer	0.000159	0.00231	CcSEcCtD
Vincristine—ABCG2—mammalian vulva—skin cancer	0.000158	0.00532	CbGeAlD
Vincristine—Erectile dysfunction—Temozolomide—skin cancer	0.000157	0.00228	CcSEcCtD
Vincristine—TUBB—lymph node—skin cancer	0.000157	0.0053	CbGeAlD
Vincristine—Hyperhidrosis—Imiquimod—skin cancer	0.000157	0.00227	CcSEcCtD
Vincristine—TUBB2A—lymph node—skin cancer	0.000156	0.00527	CbGeAlD
Vincristine—Photosensitivity reaction—Temozolomide—skin cancer	0.000156	0.00226	CcSEcCtD
Vincristine—Weight decreased—Temozolomide—skin cancer	0.000155	0.00224	CcSEcCtD
Vincristine—Anorexia—Imiquimod—skin cancer	0.000155	0.00224	CcSEcCtD
Vincristine—TUBB6—lymph node—skin cancer	0.000154	0.0052	CbGeAlD
Vincristine—Pneumonia—Temozolomide—skin cancer	0.000153	0.00222	CcSEcCtD
Vincristine—Depression—Temozolomide—skin cancer	0.000152	0.0022	CcSEcCtD
Vincristine—Body temperature increased—Vemurafenib—skin cancer	0.00015	0.00218	CcSEcCtD
Vincristine—Pancytopenia—Fluorouracil—skin cancer	0.00015	0.00217	CcSEcCtD
Vincristine—Neuropathy peripheral—Temozolomide—skin cancer	0.000149	0.00217	CcSEcCtD
Vincristine—Stomatitis—Temozolomide—skin cancer	0.000149	0.00215	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000148	0.00214	CcSEcCtD
Vincristine—RALBP1—RalA downstream regulated genes—HRAS—skin cancer	0.000147	0.0259	CbGpPWpGaD
Vincristine—Deafness—Docetaxel—skin cancer	0.000147	0.00213	CcSEcCtD
Vincristine—Insomnia—Imiquimod—skin cancer	0.000147	0.00213	CcSEcCtD
Vincristine—Hepatic failure—Docetaxel—skin cancer	0.000146	0.00212	CcSEcCtD
Vincristine—Paraesthesia—Imiquimod—skin cancer	0.000146	0.00211	CcSEcCtD
Vincristine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000144	0.00208	CcSEcCtD
Vincristine—Alopecia—Bleomycin—skin cancer	0.000143	0.00208	CcSEcCtD
Vincristine—Pneumonia—Fluorouracil—skin cancer	0.000141	0.00205	CcSEcCtD
Vincristine—Decreased appetite—Imiquimod—skin cancer	0.000141	0.00205	CcSEcCtD
Vincristine—Hypersensitivity—Vemurafenib—skin cancer	0.00014	0.00203	CcSEcCtD
Vincristine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00014	0.00203	CcSEcCtD
Vincristine—Fatigue—Imiquimod—skin cancer	0.00014	0.00203	CcSEcCtD
Vincristine—Pain—Imiquimod—skin cancer	0.000139	0.00201	CcSEcCtD
Vincristine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000138	0.00201	CcSEcCtD
Vincristine—Myocardial infarction—Fluorouracil—skin cancer	0.000138	0.002	CcSEcCtD
Vincristine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000138	0.002	CcSEcCtD
Vincristine—ABCG2—Fluoropyrimidine Activity—XRCC3—skin cancer	0.000137	0.0241	CbGpPWpGaD
Vincristine—Stomatitis—Fluorouracil—skin cancer	0.000137	0.00199	CcSEcCtD
Vincristine—Asthenia—Vemurafenib—skin cancer	0.000136	0.00198	CcSEcCtD
Vincristine—Hallucination—Temozolomide—skin cancer	0.000136	0.00197	CcSEcCtD
Vincristine—Hypoaesthesia—Temozolomide—skin cancer	0.000136	0.00197	CcSEcCtD
Vincristine—ABCC3—lymph node—skin cancer	0.000136	0.00457	CbGeAlD
Vincristine—Urinary tract disorder—Temozolomide—skin cancer	0.000135	0.00196	CcSEcCtD
Vincristine—ABCC10—lymph node—skin cancer	0.000135	0.00455	CbGeAlD
Vincristine—Connective tissue disorder—Temozolomide—skin cancer	0.000134	0.00195	CcSEcCtD
Vincristine—Urethral disorder—Temozolomide—skin cancer	0.000134	0.00195	CcSEcCtD
Vincristine—TUBB4B—lymph node—skin cancer	0.000134	0.00452	CbGeAlD
Vincristine—Alopecia—Dactinomycin—skin cancer	0.000134	0.00194	CcSEcCtD
Vincristine—Gastrointestinal pain—Imiquimod—skin cancer	0.000133	0.00192	CcSEcCtD
Vincristine—Hyponatraemia—Docetaxel—skin cancer	0.000132	0.00192	CcSEcCtD
Vincristine—Pain in extremity—Docetaxel—skin cancer	0.000132	0.00191	CcSEcCtD
Vincristine—TUBB2A—Signaling events mediated by HDAC Class III—FOXO4—skin cancer	0.000131	0.0231	CbGpPWpGaD
Vincristine—Anaemia—Bleomycin—skin cancer	0.00013	0.00189	CcSEcCtD
Vincristine—Diarrhoea—Vemurafenib—skin cancer	0.00013	0.00189	CcSEcCtD
Vincristine—Body temperature increased—Imiquimod—skin cancer	0.000128	0.00186	CcSEcCtD
Vincristine—Abdominal pain—Imiquimod—skin cancer	0.000128	0.00186	CcSEcCtD
Vincristine—Cardiac disorder—Temozolomide—skin cancer	0.000127	0.00184	CcSEcCtD
Vincristine—Leukopenia—Bleomycin—skin cancer	0.000126	0.00183	CcSEcCtD
Vincristine—Dizziness—Vemurafenib—skin cancer	0.000126	0.00182	CcSEcCtD
Vincristine—Hypoaesthesia—Fluorouracil—skin cancer	0.000125	0.00182	CcSEcCtD
Vincristine—Angiopathy—Temozolomide—skin cancer	0.000124	0.0018	CcSEcCtD
Vincristine—Ataxia—Docetaxel—skin cancer	0.000124	0.00179	CcSEcCtD
Vincristine—Mediastinal disorder—Temozolomide—skin cancer	0.000123	0.00179	CcSEcCtD
Vincristine—Dehydration—Docetaxel—skin cancer	0.000122	0.00177	CcSEcCtD
Vincristine—Anaemia—Dactinomycin—skin cancer	0.000122	0.00177	CcSEcCtD
Vincristine—Vomiting—Vemurafenib—skin cancer	0.000121	0.00175	CcSEcCtD
Vincristine—Alopecia—Temozolomide—skin cancer	0.000121	0.00175	CcSEcCtD
Vincristine—Myalgia—Bleomycin—skin cancer	0.00012	0.00174	CcSEcCtD
Vincristine—Rash—Vemurafenib—skin cancer	0.00012	0.00174	CcSEcCtD
Vincristine—Mental disorder—Temozolomide—skin cancer	0.00012	0.00174	CcSEcCtD
Vincristine—Dermatitis—Vemurafenib—skin cancer	0.00012	0.00174	CcSEcCtD
Vincristine—Hypersensitivity—Imiquimod—skin cancer	0.00012	0.00173	CcSEcCtD
Vincristine—Headache—Vemurafenib—skin cancer	0.000119	0.00173	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000118	0.00172	CcSEcCtD
Vincristine—Leukopenia—Dactinomycin—skin cancer	0.000118	0.00171	CcSEcCtD
Vincristine—Asthenia—Imiquimod—skin cancer	0.000116	0.00169	CcSEcCtD
Vincristine—SLC22A3—lymph node—skin cancer	0.000115	0.00389	CbGeAlD
Vincristine—Oedema—Bleomycin—skin cancer	0.000115	0.00167	CcSEcCtD
Vincristine—Anaphylactic shock—Bleomycin—skin cancer	0.000115	0.00167	CcSEcCtD
Vincristine—Back pain—Temozolomide—skin cancer	0.000115	0.00167	CcSEcCtD
Vincristine—Infection—Bleomycin—skin cancer	0.000114	0.00166	CcSEcCtD
Vincristine—Nausea—Vemurafenib—skin cancer	0.000113	0.00164	CcSEcCtD
Vincristine—Thrombocytopenia—Bleomycin—skin cancer	0.000113	0.00164	CcSEcCtD
Vincristine—Myalgia—Dactinomycin—skin cancer	0.000112	0.00163	CcSEcCtD
Vincristine—Alopecia—Fluorouracil—skin cancer	0.000111	0.00162	CcSEcCtD
Vincristine—Diarrhoea—Imiquimod—skin cancer	0.000111	0.00161	CcSEcCtD
Vincristine—Anaemia—Temozolomide—skin cancer	0.00011	0.0016	CcSEcCtD
Vincristine—Anorexia—Bleomycin—skin cancer	0.00011	0.00159	CcSEcCtD
Vincristine—Agitation—Temozolomide—skin cancer	0.000109	0.00159	CcSEcCtD
Vincristine—ABCC2—lymph node—skin cancer	0.000108	0.00365	CbGeAlD
Vincristine—Pancytopenia—Docetaxel—skin cancer	0.000108	0.00157	CcSEcCtD
Vincristine—Hypotension—Bleomycin—skin cancer	0.000108	0.00156	CcSEcCtD
Vincristine—Oedema—Dactinomycin—skin cancer	0.000107	0.00156	CcSEcCtD
Vincristine—Dizziness—Imiquimod—skin cancer	0.000107	0.00156	CcSEcCtD
Vincristine—Vertigo—Temozolomide—skin cancer	0.000107	0.00155	CcSEcCtD
Vincristine—Infection—Dactinomycin—skin cancer	0.000107	0.00155	CcSEcCtD
Vincristine—Leukopenia—Temozolomide—skin cancer	0.000107	0.00155	CcSEcCtD
Vincristine—Neutropenia—Docetaxel—skin cancer	0.000106	0.00154	CcSEcCtD
Vincristine—Thrombocytopenia—Dactinomycin—skin cancer	0.000105	0.00153	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000105	0.00152	CcSEcCtD
Vincristine—Paraesthesia—Bleomycin—skin cancer	0.000103	0.0015	CcSEcCtD
Vincristine—Convulsion—Temozolomide—skin cancer	0.000103	0.0015	CcSEcCtD
Vincristine—Vomiting—Imiquimod—skin cancer	0.000103	0.0015	CcSEcCtD
Vincristine—Weight decreased—Docetaxel—skin cancer	0.000103	0.00149	CcSEcCtD
Vincristine—Hypertension—Temozolomide—skin cancer	0.000103	0.00149	CcSEcCtD
Vincristine—Anorexia—Dactinomycin—skin cancer	0.000102	0.00149	CcSEcCtD
Vincristine—Rash—Imiquimod—skin cancer	0.000102	0.00148	CcSEcCtD
Vincristine—Dermatitis—Imiquimod—skin cancer	0.000102	0.00148	CcSEcCtD
Vincristine—Pneumonia—Docetaxel—skin cancer	0.000102	0.00148	CcSEcCtD
Vincristine—Headache—Imiquimod—skin cancer	0.000102	0.00147	CcSEcCtD
Vincristine—Anaemia—Fluorouracil—skin cancer	0.000101	0.00147	CcSEcCtD
Vincristine—Myalgia—Temozolomide—skin cancer	0.000101	0.00147	CcSEcCtD
Vincristine—Decreased appetite—Bleomycin—skin cancer	0.0001	0.00145	CcSEcCtD
Vincristine—Acute coronary syndrome—Docetaxel—skin cancer	9.99e-05	0.00145	CcSEcCtD
Vincristine—Myocardial infarction—Docetaxel—skin cancer	9.93e-05	0.00144	CcSEcCtD
Vincristine—Neuropathy peripheral—Docetaxel—skin cancer	9.93e-05	0.00144	CcSEcCtD
Vincristine—Stomatitis—Docetaxel—skin cancer	9.88e-05	0.00143	CcSEcCtD
Vincristine—Pain—Bleomycin—skin cancer	9.85e-05	0.00143	CcSEcCtD
Vincristine—Leukopenia—Fluorouracil—skin cancer	9.82e-05	0.00142	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Dactinomycin—skin cancer	9.79e-05	0.00142	CcSEcCtD
Vincristine—Anaphylactic shock—Temozolomide—skin cancer	9.72e-05	0.00141	CcSEcCtD
Vincristine—Oedema—Temozolomide—skin cancer	9.72e-05	0.00141	CcSEcCtD
Vincristine—Infection—Temozolomide—skin cancer	9.66e-05	0.0014	CcSEcCtD
Vincristine—Nausea—Imiquimod—skin cancer	9.63e-05	0.0014	CcSEcCtD
Vincristine—ABCC1—lymph node—skin cancer	9.54e-05	0.00322	CbGeAlD
Vincristine—Nervous system disorder—Temozolomide—skin cancer	9.53e-05	0.00138	CcSEcCtD
Vincristine—Thrombocytopenia—Temozolomide—skin cancer	9.52e-05	0.00138	CcSEcCtD
Vincristine—Convulsion—Fluorouracil—skin cancer	9.51e-05	0.00138	CcSEcCtD
Vincristine—CYP3A4—female reproductive system—skin cancer	9.41e-05	0.00317	CbGeAlD
Vincristine—Hyperhidrosis—Temozolomide—skin cancer	9.4e-05	0.00136	CcSEcCtD
Vincristine—Myalgia—Fluorouracil—skin cancer	9.34e-05	0.00136	CcSEcCtD
Vincristine—Decreased appetite—Dactinomycin—skin cancer	9.34e-05	0.00135	CcSEcCtD
Vincristine—Fatigue—Dactinomycin—skin cancer	9.27e-05	0.00134	CcSEcCtD
Vincristine—Anorexia—Temozolomide—skin cancer	9.27e-05	0.00134	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—RASA1—skin cancer	9.2e-05	0.0162	CbGpPWpGaD
Vincristine—Pain—Dactinomycin—skin cancer	9.19e-05	0.00133	CcSEcCtD
Vincristine—Body temperature increased—Bleomycin—skin cancer	9.11e-05	0.00132	CcSEcCtD
Vincristine—Hypoaesthesia—Docetaxel—skin cancer	9.05e-05	0.00131	CcSEcCtD
Vincristine—Urinary tract disorder—Docetaxel—skin cancer	8.99e-05	0.0013	CcSEcCtD
Vincristine—ABCB1—epithelium—skin cancer	8.97e-05	0.00302	CbGeAlD
Vincristine—Anaphylactic shock—Fluorouracil—skin cancer	8.96e-05	0.0013	CcSEcCtD
Vincristine—Oedema—Fluorouracil—skin cancer	8.96e-05	0.0013	CcSEcCtD
Vincristine—Connective tissue disorder—Docetaxel—skin cancer	8.94e-05	0.0013	CcSEcCtD
Vincristine—Urethral disorder—Docetaxel—skin cancer	8.92e-05	0.00129	CcSEcCtD
Vincristine—Infection—Fluorouracil—skin cancer	8.9e-05	0.00129	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Temozolomide—skin cancer	8.86e-05	0.00128	CcSEcCtD
Vincristine—Insomnia—Temozolomide—skin cancer	8.79e-05	0.00128	CcSEcCtD
Vincristine—Gastrointestinal pain—Dactinomycin—skin cancer	8.79e-05	0.00127	CcSEcCtD
Vincristine—Nervous system disorder—Fluorouracil—skin cancer	8.78e-05	0.00127	CcSEcCtD
Vincristine—Thrombocytopenia—Fluorouracil—skin cancer	8.77e-05	0.00127	CcSEcCtD
Vincristine—Paraesthesia—Temozolomide—skin cancer	8.73e-05	0.00127	CcSEcCtD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	8.7e-05	0.0153	CbGpPWpGaD
Vincristine—Anorexia—Fluorouracil—skin cancer	8.54e-05	0.00124	CcSEcCtD
Vincristine—Abdominal pain—Dactinomycin—skin cancer	8.5e-05	0.00123	CcSEcCtD
Vincristine—Body temperature increased—Dactinomycin—skin cancer	8.5e-05	0.00123	CcSEcCtD
Vincristine—Hypersensitivity—Bleomycin—skin cancer	8.49e-05	0.00123	CcSEcCtD
Vincristine—Decreased appetite—Temozolomide—skin cancer	8.45e-05	0.00123	CcSEcCtD
Vincristine—Cardiac disorder—Docetaxel—skin cancer	8.44e-05	0.00122	CcSEcCtD
Vincristine—Gastrointestinal disorder—Temozolomide—skin cancer	8.39e-05	0.00122	CcSEcCtD
Vincristine—Fatigue—Temozolomide—skin cancer	8.38e-05	0.00122	CcSEcCtD
Vincristine—Hypotension—Fluorouracil—skin cancer	8.37e-05	0.00121	CcSEcCtD
Vincristine—Pain—Temozolomide—skin cancer	8.31e-05	0.00121	CcSEcCtD
Vincristine—Constipation—Temozolomide—skin cancer	8.31e-05	0.00121	CcSEcCtD
Vincristine—Asthenia—Bleomycin—skin cancer	8.27e-05	0.0012	CcSEcCtD
Vincristine—Angiopathy—Docetaxel—skin cancer	8.25e-05	0.0012	CcSEcCtD
Vincristine—Mediastinal disorder—Docetaxel—skin cancer	8.2e-05	0.00119	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Fluorouracil—skin cancer	8.16e-05	0.00118	CcSEcCtD
Vincristine—Insomnia—Fluorouracil—skin cancer	8.1e-05	0.00117	CcSEcCtD
Vincristine—Paraesthesia—Fluorouracil—skin cancer	8.04e-05	0.00117	CcSEcCtD
Vincristine—Alopecia—Docetaxel—skin cancer	8.04e-05	0.00117	CcSEcCtD
Vincristine—Mental disorder—Docetaxel—skin cancer	7.97e-05	0.00116	CcSEcCtD
Vincristine—Gastrointestinal pain—Temozolomide—skin cancer	7.95e-05	0.00115	CcSEcCtD
Vincristine—Hypersensitivity—Dactinomycin—skin cancer	7.92e-05	0.00115	CcSEcCtD
Vincristine—ABCG2—lymph node—skin cancer	7.9e-05	0.00266	CbGeAlD
Vincristine—Decreased appetite—Fluorouracil—skin cancer	7.79e-05	0.00113	CcSEcCtD
Vincristine—ABCB1—mammalian vulva—skin cancer	7.78e-05	0.00262	CbGeAlD
Vincristine—Gastrointestinal disorder—Fluorouracil—skin cancer	7.73e-05	0.00112	CcSEcCtD
Vincristine—Asthenia—Dactinomycin—skin cancer	7.71e-05	0.00112	CcSEcCtD
Vincristine—Body temperature increased—Temozolomide—skin cancer	7.68e-05	0.00111	CcSEcCtD
Vincristine—Abdominal pain—Temozolomide—skin cancer	7.68e-05	0.00111	CcSEcCtD
Vincristine—Back pain—Docetaxel—skin cancer	7.66e-05	0.00111	CcSEcCtD
Vincristine—Pain—Fluorouracil—skin cancer	7.66e-05	0.00111	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—FOXO4—skin cancer	7.55e-05	0.0133	CbGpPWpGaD
Vincristine—Diarrhoea—Dactinomycin—skin cancer	7.35e-05	0.00107	CcSEcCtD
Vincristine—Vomiting—Bleomycin—skin cancer	7.33e-05	0.00106	CcSEcCtD
Vincristine—Anaemia—Docetaxel—skin cancer	7.32e-05	0.00106	CcSEcCtD
Vincristine—Rash—Bleomycin—skin cancer	7.27e-05	0.00105	CcSEcCtD
Vincristine—Dermatitis—Bleomycin—skin cancer	7.26e-05	0.00105	CcSEcCtD
Vincristine—Hypersensitivity—Temozolomide—skin cancer	7.16e-05	0.00104	CcSEcCtD
Vincristine—Leukopenia—Docetaxel—skin cancer	7.09e-05	0.00103	CcSEcCtD
Vincristine—Body temperature increased—Fluorouracil—skin cancer	7.08e-05	0.00103	CcSEcCtD
Vincristine—ABCC3—Fluoropyrimidine Activity—ERCC2—skin cancer	6.99e-05	0.0123	CbGpPWpGaD
Vincristine—Asthenia—Temozolomide—skin cancer	6.97e-05	0.00101	CcSEcCtD
Vincristine—ABCB1—lymphoid tissue—skin cancer	6.91e-05	0.00233	CbGeAlD
Vincristine—Convulsion—Docetaxel—skin cancer	6.86e-05	0.000995	CcSEcCtD
Vincristine—Nausea—Bleomycin—skin cancer	6.84e-05	0.000993	CcSEcCtD
Vincristine—Hypertension—Docetaxel—skin cancer	6.84e-05	0.000992	CcSEcCtD
Vincristine—Vomiting—Dactinomycin—skin cancer	6.83e-05	0.000991	CcSEcCtD
Vincristine—Rash—Dactinomycin—skin cancer	6.78e-05	0.000983	CcSEcCtD
Vincristine—Myalgia—Docetaxel—skin cancer	6.74e-05	0.000978	CcSEcCtD
Vincristine—ABCB1—female reproductive system—skin cancer	6.66e-05	0.00225	CbGeAlD
Vincristine—Diarrhoea—Temozolomide—skin cancer	6.65e-05	0.000965	CcSEcCtD
Vincristine—Hypersensitivity—Fluorouracil—skin cancer	6.6e-05	0.000957	CcSEcCtD
Vincristine—Anaphylactic shock—Docetaxel—skin cancer	6.46e-05	0.000938	CcSEcCtD
Vincristine—Oedema—Docetaxel—skin cancer	6.46e-05	0.000938	CcSEcCtD
Vincristine—Dizziness—Temozolomide—skin cancer	6.43e-05	0.000932	CcSEcCtD
Vincristine—Infection—Docetaxel—skin cancer	6.42e-05	0.000931	CcSEcCtD
Vincristine—Nausea—Dactinomycin—skin cancer	6.38e-05	0.000926	CcSEcCtD
Vincristine—Nervous system disorder—Docetaxel—skin cancer	6.34e-05	0.000919	CcSEcCtD
Vincristine—Thrombocytopenia—Docetaxel—skin cancer	6.33e-05	0.000918	CcSEcCtD
Vincristine—Vomiting—Temozolomide—skin cancer	6.18e-05	0.000896	CcSEcCtD
Vincristine—Anorexia—Docetaxel—skin cancer	6.16e-05	0.000894	CcSEcCtD
Vincristine—Rash—Temozolomide—skin cancer	6.13e-05	0.000889	CcSEcCtD
Vincristine—Diarrhoea—Fluorouracil—skin cancer	6.13e-05	0.000889	CcSEcCtD
Vincristine—Dermatitis—Temozolomide—skin cancer	6.12e-05	0.000888	CcSEcCtD
Vincristine—Headache—Temozolomide—skin cancer	6.09e-05	0.000883	CcSEcCtD
Vincristine—Hypotension—Docetaxel—skin cancer	6.04e-05	0.000876	CcSEcCtD
Vincristine—Dizziness—Fluorouracil—skin cancer	5.92e-05	0.000859	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Docetaxel—skin cancer	5.89e-05	0.000854	CcSEcCtD
Vincristine—Insomnia—Docetaxel—skin cancer	5.85e-05	0.000848	CcSEcCtD
Vincristine—Paraesthesia—Docetaxel—skin cancer	5.8e-05	0.000842	CcSEcCtD
Vincristine—Nausea—Temozolomide—skin cancer	5.77e-05	0.000837	CcSEcCtD
Vincristine—Vomiting—Fluorouracil—skin cancer	5.69e-05	0.000826	CcSEcCtD
Vincristine—Rash—Fluorouracil—skin cancer	5.65e-05	0.000819	CcSEcCtD
Vincristine—Dermatitis—Fluorouracil—skin cancer	5.64e-05	0.000818	CcSEcCtD
Vincristine—Decreased appetite—Docetaxel—skin cancer	5.62e-05	0.000815	CcSEcCtD
Vincristine—Headache—Fluorouracil—skin cancer	5.61e-05	0.000814	CcSEcCtD
Vincristine—Gastrointestinal disorder—Docetaxel—skin cancer	5.58e-05	0.000809	CcSEcCtD
Vincristine—Fatigue—Docetaxel—skin cancer	5.57e-05	0.000808	CcSEcCtD
Vincristine—ABCB1—head—skin cancer	5.56e-05	0.00188	CbGeAlD
Vincristine—Pain—Docetaxel—skin cancer	5.53e-05	0.000802	CcSEcCtD
Vincristine—Constipation—Docetaxel—skin cancer	5.53e-05	0.000802	CcSEcCtD
Vincristine—Nausea—Fluorouracil—skin cancer	5.32e-05	0.000772	CcSEcCtD
Vincristine—Gastrointestinal pain—Docetaxel—skin cancer	5.29e-05	0.000767	CcSEcCtD
Vincristine—ABCC10—Transmembrane transport of small molecules—SLC12A2—skin cancer	5.24e-05	0.00922	CbGpPWpGaD
Vincristine—Body temperature increased—Docetaxel—skin cancer	5.11e-05	0.000741	CcSEcCtD
Vincristine—Abdominal pain—Docetaxel—skin cancer	5.11e-05	0.000741	CcSEcCtD
Vincristine—ABCC1—S1P1 pathway—PTGS2—skin cancer	5.11e-05	0.00899	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—RHOU—skin cancer	5.02e-05	0.00882	CbGpPWpGaD
Vincristine—ABCG2—Fluoropyrimidine Activity—ERCC2—skin cancer	4.82e-05	0.00848	CbGpPWpGaD
Vincristine—Hypersensitivity—Docetaxel—skin cancer	4.76e-05	0.000691	CcSEcCtD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—PLIN2—skin cancer	4.7e-05	0.00827	CbGpPWpGaD
Vincristine—Asthenia—Docetaxel—skin cancer	4.64e-05	0.000673	CcSEcCtD
Vincristine—TUBA4A—Metabolism of proteins—EXOC2—skin cancer	4.63e-05	0.00815	CbGpPWpGaD
Vincristine—Diarrhoea—Docetaxel—skin cancer	4.42e-05	0.000641	CcSEcCtD
Vincristine—SLC22A3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	4.35e-05	0.00764	CbGpPWpGaD
Vincristine—Dizziness—Docetaxel—skin cancer	4.27e-05	0.00062	CcSEcCtD
Vincristine—Vomiting—Docetaxel—skin cancer	4.11e-05	0.000596	CcSEcCtD
Vincristine—Rash—Docetaxel—skin cancer	4.08e-05	0.000591	CcSEcCtD
Vincristine—Dermatitis—Docetaxel—skin cancer	4.07e-05	0.000591	CcSEcCtD
Vincristine—Headache—Docetaxel—skin cancer	4.05e-05	0.000587	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—BRAF—skin cancer	3.99e-05	0.00702	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—EXOC2—skin cancer	3.97e-05	0.00699	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—EXOC2—skin cancer	3.97e-05	0.00699	CbGpPWpGaD
Vincristine—ABCB1—lymph node—skin cancer	3.9e-05	0.00131	CbGeAlD
Vincristine—Nausea—Docetaxel—skin cancer	3.84e-05	0.000557	CcSEcCtD
Vincristine—TUBB3—Metabolism of proteins—EXOC2—skin cancer	3.84e-05	0.00675	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—EXOC2—skin cancer	3.72e-05	0.00654	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—EXOC2—skin cancer	3.64e-05	0.0064	CbGpPWpGaD
Vincristine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—skin cancer	3.33e-05	0.00587	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.31e-05	0.00583	CbGpPWpGaD
Vincristine—TUBB2B—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.31e-05	0.00583	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—EXOC2—skin cancer	3.26e-05	0.00574	CbGpPWpGaD
Vincristine—TUBB3—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.2e-05	0.00563	CbGpPWpGaD
Vincristine—TUBB2A—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.1e-05	0.00545	CbGpPWpGaD
Vincristine—TUBB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.03e-05	0.00533	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—EXOC2—skin cancer	2.99e-05	0.00525	CbGpPWpGaD
Vincristine—TUBB4A—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.72e-05	0.00479	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—TERT—skin cancer	2.6e-05	0.00457	CbGpPWpGaD
Vincristine—ABCC3—Fluoropyrimidine Activity—TP53—skin cancer	2.5e-05	0.00439	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.49e-05	0.00438	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTCH2—skin cancer	2.45e-05	0.00431	CbGpPWpGaD
Vincristine—ABCC1—Arachidonic acid metabolism—PTGS2—skin cancer	2.36e-05	0.00414	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.35e-05	0.00413	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MLH1—skin cancer	2.33e-05	0.00411	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.25e-05	0.00396	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.21e-05	0.00388	CbGpPWpGaD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—KRAS—skin cancer	2.16e-05	0.0038	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.03e-05	0.00357	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MLH1—skin cancer	1.98e-05	0.00349	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—GLI2—skin cancer	1.86e-05	0.00327	CbGpPWpGaD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—skin cancer	1.84e-05	0.00323	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MC1R—skin cancer	1.77e-05	0.00311	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.76e-05	0.0031	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—GLI1—skin cancer	1.75e-05	0.00307	CbGpPWpGaD
Vincristine—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	1.72e-05	0.00303	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SUFU—skin cancer	1.65e-05	0.00291	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MLH1—skin cancer	1.64e-05	0.00289	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.61e-05	0.00283	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.59e-05	0.0028	CbGpPWpGaD
Vincristine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	1.51e-05	0.00266	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MLH1—skin cancer	1.5e-05	0.00265	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	1.4e-05	0.00247	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.4e-05	0.00246	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDK4—skin cancer	1.33e-05	0.00233	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TERT—skin cancer	1.33e-05	0.00233	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SHH—skin cancer	1.26e-05	0.00222	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—RASA1—skin cancer	1.25e-05	0.00221	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SMO—skin cancer	1.2e-05	0.0021	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTCH1—skin cancer	1.2e-05	0.0021	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDK4—skin cancer	1.19e-05	0.00209	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTGER4—skin cancer	1.16e-05	0.00205	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDK4—skin cancer	1.13e-05	0.00198	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TERT—skin cancer	1.13e-05	0.00198	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	1.1e-05	0.00194	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PLIN2—skin cancer	1.09e-05	0.00192	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—ERCC2—skin cancer	1.06e-05	0.00186	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PLIN2—skin cancer	1.05e-05	0.00184	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.04e-05	0.00184	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—FOXO4—skin cancer	1.03e-05	0.00181	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CDKN2A—skin cancer	1.01e-05	0.00178	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDK4—skin cancer	1.01e-05	0.00177	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PLIN2—skin cancer	1e-05	0.00176	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDK4—skin cancer	9.35e-06	0.00164	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TERT—skin cancer	9.34e-06	0.00164	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CDKN2A—skin cancer	9.07e-06	0.0016	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CSPG4—skin cancer	8.79e-06	0.00155	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CDKN2A—skin cancer	8.62e-06	0.00152	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDK4—skin cancer	8.55e-06	0.0015	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TERT—skin cancer	8.54e-06	0.0015	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CSPG4—skin cancer	8.43e-06	0.00148	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDK4—skin cancer	8.36e-06	0.00147	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CSPG4—skin cancer	8.08e-06	0.00142	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PLIN2—skin cancer	7.86e-06	0.00138	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDKN2A—skin cancer	7.71e-06	0.00136	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDK4—skin cancer	7.65e-06	0.00134	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	7.57e-06	0.00133	CbGpPWpGaD
Vincristine—ABCC1—Disease—CSPG4—skin cancer	7.56e-06	0.00133	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—skin cancer	7.15e-06	0.00126	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—NRAS—skin cancer	6.99e-06	0.00123	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PLIN2—skin cancer	6.91e-06	0.00122	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TERT—skin cancer	6.87e-06	0.00121	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PLIN2—skin cancer	6.85e-06	0.00121	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—skin cancer	6.54e-06	0.00115	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDKN2A—skin cancer	6.39e-06	0.00112	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CSPG4—skin cancer	6.33e-06	0.00111	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—KRAS—skin cancer	6.02e-06	0.00106	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ENO2—skin cancer	5.98e-06	0.00105	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDKN2A—skin cancer	5.84e-06	0.00103	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ENO2—skin cancer	5.73e-06	0.00101	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CSPG4—skin cancer	5.57e-06	0.00098	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CSPG4—skin cancer	5.52e-06	0.000972	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ENO2—skin cancer	5.49e-06	0.000967	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—BRAF—skin cancer	5.44e-06	0.000957	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	5.37e-06	0.000944	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TP53—skin cancer	5.35e-06	0.000941	CbGpPWpGaD
Vincristine—ABCC1—Disease—SHH—skin cancer	5.14e-06	0.000904	CbGpPWpGaD
Vincristine—ABCC1—Disease—ENO2—skin cancer	5.14e-06	0.000904	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—HRAS—skin cancer	5.11e-06	0.0009	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—skin cancer	5.05e-06	0.000888	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PLIN2—skin cancer	4.95e-06	0.000871	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.48e-06	0.000788	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ENO2—skin cancer	4.31e-06	0.000757	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.3e-06	0.000756	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—skin cancer	4.29e-06	0.000755	CbGpPWpGaD
Vincristine—ABCC1—Disease—FOXO4—skin cancer	4.19e-06	0.000737	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CSPG4—skin cancer	3.99e-06	0.000702	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	3.84e-06	0.000675	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ENO2—skin cancer	3.79e-06	0.000666	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ENO2—skin cancer	3.75e-06	0.000661	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PLIN2—skin cancer	3.74e-06	0.000658	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—skin cancer	3.56e-06	0.000625	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ERCC2—skin cancer	3.47e-06	0.000611	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NRAS—skin cancer	3.42e-06	0.000601	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.37e-06	0.000592	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ERCC2—skin cancer	3.33e-06	0.000586	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—skin cancer	3.25e-06	0.000572	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ERCC2—skin cancer	3.19e-06	0.000561	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CSPG4—skin cancer	3.01e-06	0.00053	CbGpPWpGaD
Vincristine—ABCC1—Disease—ERCC2—skin cancer	2.99e-06	0.000525	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KRAS—skin cancer	2.94e-06	0.000518	CbGpPWpGaD
Vincristine—ABCC1—Disease—TERT—skin cancer	2.8e-06	0.000492	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ENO2—skin cancer	2.71e-06	0.000477	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—skin cancer	2.62e-06	0.00046	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.57e-06	0.000452	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—skin cancer	2.5e-06	0.00044	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ERCC2—skin cancer	2.5e-06	0.00044	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL6—skin cancer	2.39e-06	0.000421	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PLIN2—skin cancer	2.3e-06	0.000405	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.28e-06	0.000402	CbGpPWpGaD
Vincristine—ABCC1—Disease—BRAF—skin cancer	2.22e-06	0.00039	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ERCC2—skin cancer	2.2e-06	0.000387	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ERCC2—skin cancer	2.18e-06	0.000384	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTGS2—skin cancer	2.08e-06	0.000366	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ENO2—skin cancer	2.05e-06	0.00036	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTGS2—skin cancer	2e-06	0.000351	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTGS2—skin cancer	1.91e-06	0.000337	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CSPG4—skin cancer	1.86e-06	0.000327	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTGS2—skin cancer	1.79e-06	0.000315	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ERCC2—skin cancer	1.58e-06	0.000277	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTGS2—skin cancer	1.5e-06	0.000264	CbGpPWpGaD
Vincristine—ABCC1—Disease—NRAS—skin cancer	1.39e-06	0.000245	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTGS2—skin cancer	1.32e-06	0.000232	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTGS2—skin cancer	1.31e-06	0.00023	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ENO2—skin cancer	1.26e-06	0.000222	CbGpPWpGaD
Vincristine—ABCC1—Disease—KRAS—skin cancer	1.2e-06	0.000211	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ERCC2—skin cancer	1.19e-06	0.000209	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—skin cancer	1.02e-06	0.000179	CbGpPWpGaD
Vincristine—ABCC1—Disease—IL6—skin cancer	9.75e-07	0.000172	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTGS2—skin cancer	9.45e-07	0.000166	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ERCC2—skin cancer	7.33e-07	0.000129	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTGS2—skin cancer	7.13e-07	0.000125	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTGS2—skin cancer	4.39e-07	7.73e-05	CbGpPWpGaD
